Medical Manufacturing Technologies Acquires Ireland-Based Somex Automation

Medical Manufacturing Technologies, Inc. (MMT), a portfolio company of Arcline Investment Management and a leading global provider of medical device manufacturing solutions, announced the acquisition of Somex Automation (Somex), an Ireland-based provider of custom automation equipment and processes for the medical device manufacturing industry. The Somex product offering will go to market under our MMT Automation brand.

As part of the transaction, Medical Manufacturing Technologies welcomes 34 new employees who will continue to operate out of Somex’s Cork and Ballyvourney facilities in Ireland.

“The acquisition of Somex Automation is a milestone for our company,” said Robbie Atkinson, CEO of Medical Manufacturing Technologies. “We are excited to bring a strong business with highly skilled employees into our family.” Atkinson went on to highlight how the automation and process integration expertise of Somex will become a flagship offering of the MMT Automation brand. “This transaction allows MMT to seamlessly integrate our end-to-end medical device manufacturing to further support our customers on their quest to increase production and expand their ‘lights out’ operation capabilities. The Somex team’s expertise and history of implementation is an asset to our customers.”

“This transaction allows us to grow the bespoke automation and integration solutions offered to medical device manufacturers across the globe,” said Michael Wall, Managing Director and founder of Somex. “We will be able to leverage the strengths of both companies and create an even more powerful offering for our customers.” Wall will join MMT as technical director.

Atkinson stated that MMT launched MMT Automation to streamline its subsidiaries’ automation offerings, further positioning Somex Automation solutions to customers across its portfolio.

“As a global leader of medical device manufacturing equipment and processes, we streamlined shared technologies and processes to ensure our customers have access to the solutions they need when they need them,” said Atkinson. “MMT Automation aligns our automation expertise across the portfolio where we can most effectively help our customers create autonomous manufacturing and continuous optimization of production lines.”

MMT offers its customers a broad portfolio of high-precision solutions for developing and manufacturing complex medical devices used in minimally invasive procedures. Its robust offering expands beyond equipment to proof-of-concept, process development, and TotalCare aftermarket support and services.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version